Radiation Dose Spike During a Complex Pelvic Angioembolization
You are assisting a pelvic angioembolization for a trauma patient with a pelvic fracture and active bleeding. The case is running long. The attending is using continuous fluoroscopy at 7.5 pps with the detector frequently close to the patient, and the C-arm is repeatedly angled steeply. The dose display shows the reference point air kerma climbing past 3 Gy, and the fluoroscopy timer is at 22 minutes. The patient is unstable and the team is focused on hemorrhage control.
1. What radiation-safety actions are appropriate now, and how do you raise them without derailing a resuscitative case?
Read the worked answer
The exam tests whether you can act on real-time dose data while respecting clinical urgency:
- Use the display as a trigger. Reference point air kerma and fluoroscopy time are actionable. Many programs have thresholds (e.g., notify at defined air kerma or dose-area product levels; some use ~5 Gy as a significant-dose notification threshold). At 3 Gy with 22 minutes of fluoro and steep angles, you are on a trajectory to a high dose - flag it now, not later.
- Practical dose-reduction moves that don't slow the case: step on the pedal only when imaging (avoid continuous run when a spot or last-image-hold suffices), collimate tightly to the region of interest, use the lowest pulse rate that answers the clinical question, keep the detector as close to the patient as geometry allows, minimize steep angles and magnification, and use last-image-hold instead of re-imaging.
- Communicate briefly and concretely - e.g., 'Dose is at 3 Gy and climbing; can we drop to 3 pps and collimate?' Framing it as a question tied to the number gets a fast response during a resuscitation.
- Track cumulative dose for the patient record and for post-procedure follow-up (skin-dose documentation and, if high, dermatology/skin assessment per policy).
Do not lecture mid-case; give the number and one or two specific asks.
2. After the case, what documentation and follow-up considerations does the high dose create?
Read the worked answer
- Record the dose metrics (reference point air kerma, dose-area product, fluoroscopy time) in the procedure record, along with the reason for the study and any dose-reduction measures used.
- Flag for follow-up if the cumulative peak skin dose is estimated to be high enough to risk deterministic skin injury (institutional thresholds vary; often around 3–5 Gy peak skin dose triggers notification). The team should document the location of the beam and consider skin assessment at a defined interval (e.g., 1–2 weeks) because radiation dermatitis/necrosis can be delayed.
- Quality review: a case that reached this dose is a candidate for a dose-review/QA discussion - what drove it (steep angles, continuous fluoro, detector distance) and what could change next time.
- Communicate to the care team so the patient's subsequent providers know about the exposure.
The judgment: convert real-time dose awareness into concrete intraprocedural actions and structured post-procedure follow-up, which is what the exam rewards over rote recall of dose limits.